VYNE Therapeutics Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
VYNE Nasdaq 2834 vynetherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for VYNE Therapeutics Inc.

Yarrow Bioscience Completes VYNE Therapeutics Merger, Begins Phase 2 Trial Dosing for YB-101 - Jul 27th, 2026 7:17 am
Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease - Jul 27th, 2026 5:00 am
VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience - Jul 23rd, 2026 2:26 pm
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience - Jul 21st, 2026 6:00 am
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience - Jul 10th, 2026 6:00 am
BC-Most Active Stocks - Dec 17th, 2025 8:30 am
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement - Dec 17th, 2025 6:00 am
VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates - Nov 6th, 2025 7:15 am
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update - Nov 6th, 2025 6:00 am
VYNE Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Aug 18th, 2025 12:37 pm
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates - Aug 14th, 2025 7:15 am
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update - Aug 14th, 2025 6:00 am
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates - Aug 12th, 2025 3:40 pm
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates - Aug 11th, 2025 4:55 pm
Catalyst Pharmaceutical (CPRX) Q2 Earnings and Revenues Surpass Estimates - Aug 6th, 2025 4:40 pm
Here's Why VYNE Therapeutics (NASDAQ:VYNE) Must Use Its Cash Wisely - Jul 31st, 2025 7:43 am
Sector Update: Health Care Stocks Decline in Late Afternoon Trading - Jul 30th, 2025 1:58 pm
VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo - Jul 30th, 2025 6:00 am